43.71
price up icon1.51%   0.65
after-market Handel nachbörslich: 43.81 0.10 +0.23%
loading

Finanzdaten der Vaxcyte Inc-Aktie (PCVX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
25.13%
226.22
180.79 162.17 139.92 152.98
Operating Income/Loss
25.13%
-226.22
-180.79 -162.17 -139.92 -152.98
Nonoperating Income/Loss
48.84%
59.65
40.08 - - -
Income/Loss From Continuing Operations Before Tax
18.37%
-166.57
-140.72 -137.08 -103.12 -128.70
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
18.37%
-166.57
-140.72 -137.08 -103.12 -128.70
Net Income/Loss
18.37%
-166.57
-140.72 -137.08 -103.12 -128.70
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.25%
136.03
135.69 4.4009 123.69 117.26
Diluted Average Shares
0.25%
136.03
135.69 4.4009 123.69 117.26
Basic Earnings Per Share
17.31%
-1.22
-1.04 -1.02 -0.83 -1.10
Diluted Earnings Per Share
17.31%
-1.22
-1.04 -1.02 -0.83 -1.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.43
price up icon 0.31%
$97.31
price down icon 0.33%
$31.50
price down icon 0.66%
$91.46
price down icon 0.15%
biotechnology ONC
$307.02
price up icon 0.32%
$166.55
price down icon 16.08%
Kapitalisierung:     |  Volumen (24h):